| Limited Competition—Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed)- RFA-AI-22-075 |
UC7
|
December 14, 2022 |
February 23, 2023 |
| Notice of Special Interest (NOSI)—Research on Gender Measurement (Admin Supp Clinical Trial Optional)- NOT-OD-23-029 |
Supp
|
December 05, 2022 |
March 01, 2023 |
| Notice of Special Interest— Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars- NOT-OD-23-031 |
Supp
|
December 01, 2022 |
October 01, 2025 |
| Notice of Special Interest (NOSI)—Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards- NOT-OD-23-032 |
Supp
|
December 01, 2022 |
October 01, 2025 |
| Notice of Special Interest (NOSI)—Administrative Supplements for R25 Data Science Training for Infectious and Immune-mediated Disease Research- NOT-AI-23-010 |
Supp
|
November 30, 2022 |
February 14, 2024 |
| Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)- NOT-AI-23-013 |
Multiple |
November 25, 2022 |
January 08, 2026 |
| Notice of Special Interest (NOSI)—Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data Ecosystem- NOT-AI-23-009 |
Supp
|
November 25, 2022 |
February 14, 2025 |
| Notice of Special Interest (NOSI)—Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine- NOT-AI-23-007 |
R21, R41/R42, R43/R44, R01
|
November 25, 2022 |
January 08, 2026 |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)- PAR-23-065 |
R24
|
November 23, 2022 |
January 08, 2026 |
| Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics- NOT-AI-23-001 |
R01, R41/R42, R43/R44, R21
|
November 23, 2022 |
January 08, 2026 |
| Notice of Special Interest (NOSI)—Complement in Fundamental Immunology- NOT-AI-23-012 |
R21, R01
|
November 23, 2022 |
January 08, 2026 |
| International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)- RFA-AI-22-067 |
U19
|
November 22, 2022 |
May 05, 2023 |
| Notice of Special Interest (NOSI)—Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship- NOT-OD-23-002 |
Supp
|
November 18, 2022 |
February 18, 2023 |
| Notice of Special Interest (NOSI)—Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) - NOT-OD-23-018 |
Supp
|
November 17, 2022 |
February 17, 2023 |
| Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)- RFA-AI-22-069 |
U19
|
November 15, 2022 |
April 08, 2023 |
| Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement, Clinical Trial Optional)- PA-23-044 |
Supp
|
November 04, 2022 |
October 26, 2025 |
| Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)- PAR-23-033 |
U19
|
October 31, 2022 |
March 15, 2025 |
| HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)- PAR-22-248 |
K01
|
October 28, 2022 |
September 08, 2025 |
| Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed)- PAR-22-247 |
R24
|
October 13, 2022 |
May 26, 2025 |
| Notice of Special Interest (NOSI)—Opportunities for HIV Cure Interventions at the Time of ART Initiation- NOT-AI-22-072 |
R01, R21
|
October 06, 2022 |
September 08, 2025 |
| Immunity in Older Adults (U01 Clinical Trial Not Allowed)- RFA-AI-22-060 |
U01
|
October 04, 2022 |
February 15, 2023 |
| Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed)- RFA-AI-22-068 |
R21/R33
|
October 03, 2022 |
February 15, 2023 |
| Genetic Tools for Understanding Rickettsial and Related Infections (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-047 |
R61/R33
|
October 03, 2022 |
February 15, 2023 |
| Notice of Special Interest (NOSI)—Targeting the Pathogen within the Arthropod Vector- NOT-AI-22-074 |
R01, R21
|
October 03, 2022 |
January 08, 2026 |
| Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)- RFA-AI-22-059 |
UM1
|
September 21, 2022 |
February 08, 2023 |
